Compare Mutual Funds
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
1.08
-
NAV
₹24.32
-
Fund Started
06 Oct 2020
-
Fund Size
₹188.90 Cr
-
Exit Load
-
-
1 Year
19.96%
-
3 Year
19.72%
-
5 Year
13.12%
-
Equity
99.78%
-
Cash
0.05%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.96% |
Eli Lilly And Co | 6.85% |
Apollo Hospitals Enterprise Ltd. | 5.71% |
Max Healthcare Institute Ltd. | 5.21% |
Divi's Laboratories Ltd. | 5.14% |
Cipla Ltd. | 4.84% |
Dr. Reddy's Laboratories Ltd. | 4.44% |
Johnson & Johnson Ltd. | 4.35% |
Lupin Ltd. | 3.62% |
Laurus Labs Ltd. | 3.48% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.
-
Launch Date
06 Oct 2020
-
